Insulin, a hormone produced by the pancreas -cells, regulates glucose metabolism
Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance
Compared with classical oral-hypoglycemic drugs, biguanides, thiazolidinediones, sulfonylureas, and alpha glucosidase inhibitors, patients receiving DPP-4i treatment have a lower incidence of hypoglycemic events and gain less weight
True lasting results call for a more complete approach
Post-Market Surveillance & Feedback Ongoing monitoring of the drugs safety and effectiveness continues after market launch
After taking retatrutide, the body begins responding to changes in hunger signaling, insulin sensitivity, and energy use